parp inhibitors for the treatment of metastic castration-resistant prostate cancer
Published 2 years ago • 248 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
1:01
choosing the correct parp inhibitor for prostate cancer
-
1:10
treatment options for patients with metastatic castration-resistant prostate cancer
-
3:47
parp inhibitors for metastatic hormone sensitive prostate cancer
-
2:09
current perspectives from clinical trials using parp inhibitors for prostate cancer
-
0:45
treatment sequencing for metastatic castration-resistant prostate cancer
-
1:21
combining a parp and pd-l1 inhibitor to treat prostate cancer
-
1:16
drug development for metastatic castration-resistant prostate cancer
-
4:02
the emerging role of parp inhibitors in prostate cancer
-
1:31
tackling disease progression whilst using parp inhibitors for prostate cancer
-
2:30
parp inhibitors plus novel endocrine agents for patients with metastatic prostate cancer
-
1:34
combination therapies for the treatment of prostate cancer
-
1:25
parp inhibitors: their applications and efficacy against prostate cancer
-
2:02
unanswered questions regarding the use of parp inhibitors for patients with mcrpc
-
12:50
parp inhibitors for metastatic castration-resistant prostate cancer
-
4:55
parp inhibitors in castrate-resistant prostate cancer
-
0:57
when is the optimal time to use parp inhibitors in prostate cancer patients?
-
0:58
biomarkers associated with parpi response in patients with castration-resistant prostate cancer
-
2:16
testing the validity of a prognostic model for castration-resistant prostate cancer
-
0:33
circulating tumor cells in management of patients with castration-resistant prostate cancer